Welcome

Celebrating Over 75 Years Of Service

The American Academy of Otolaryngic Allergy (AAOA) represents over 2,700 Board-certified otolaryngologists and health care providers. Otolaryngology, frequently referred to as Ear, Nose, and Throat (ENT), uniquely combines medical and surgical expertise to care for patients with a variety of conditions affecting the ears, nose, and throat, as well as commonly related conditions. AAOA members devote part of their practice to the diagnosis and treatment of allergic disease. The AAOA actively supports its membership through education, research, and advocacy in the care of allergic patients.

"Advance the comprehensive management of allergy and inflammatory disease in Otolaryngology-Head and Neck Surgery through training, education, and advocacy."

ADVOCACY UPDATES

CY 2021 Physician Fee Schedule Proposed Rule Summary

On August 3, the Centers for Medicare & Medicaid Services (CMS) released the Medicare Physician…

read more

Congress and Administration Take Aggressive Action to Address COVID-19 Pandemic but Providers Continue to Struggle

Congress has passed four pieces of legislation and the Centers for Medicare & Medicaid Services…

read more

USP General Chapter <797> News. Media Fill Test Kit

Implementation of the new USP General Chapter <797> Pharmaceutical Compounding — Sterile Preparations is still…

read more

Changes in MACRA

Macra 101 Image

Before the close of 2017, all physicians must take action to avoid the 4 percent cut that will be assessed in 2019 for not participating in the new Quality Payment Program (QPP) authorized by the Medicare Access and CHIP Reauthorization Act (MACRA).  Read More

CMS Announces Changes in MACRA Implementation Timeline. The Centers for Medicare and Medicaid Services (CMS) announced major changes to the implementation of the Medicare Access and CHIP Re-authorization (MACRA).
Read More

Upcoming Dates

07/15/20: Call for Scientific Papers
Learn more

09/11/20: Membership Application Deadline to be voted in at the 2020 Annual Meeting and to be eligible for AAOA Member Rate (FREE) for the 2020 Annual Meeting Learn more

12/01/20: Research Grant Cycle
Learn more

04/01/21: Fellow Exam Application Deadline
Learn more

06/01/21: Research Grant Cycle
Learn more

06/26/21: Membership Application Deadline to be eligible for AAOA Member rate for the 2021 Basic Course

EDUCATION

On Demand Content!

Register now  for the Core Allergy & Rhinology Concepts: Age of Pandemics and Beyond that is still available on demand! It is a great value for rebooting and training returning or new staff. Core Allergy offers what you need to help refresh or add allergy to your practice — everything from the clinical science to the basics of allergy from a better understanding of testing techniques, vial prep, and dose calculations to other practical implications. Core Rhinology encompassed the highly sought after rhinology content from our former IAR program.  Read More

IFAR

IFAR Impact Factor: 2.454

aaoaf-ifar

IFAR Featured Content: COVID-19 - Free Access
Endonasal instrumentation and aerosolization risk in the era of COVID‐19: simulation, literature review, and proposed mitigation strategies . Read More

Now Available

Changes in Managing Practices

Mission

Working together with AAOA staff, volunteer leadership and members will enable us to have a positive impact on our members’ practices.

Read More

Live and Online CME

Core Allergy and Rhinology Concepts: Age of Pandemics and Beyond
Learn More

Registrants! Use the access button below to Log in and click My Account at the top of the link page to get into the course event page.

2020 AAOA Annual Meeting
October 24-29, 2020
Now Virtual
Learn More and Register

AAOA Clinical Insights
Learn More and Register

USP 797 Online Module
Learn More and Register

2021 Basic Course in Allergy & Immunology
July 15-17 | Seattle, WA

News and Updates

President’s 2020 Update

Alpen Patel, MD, FAAOA on changes caused by the COVID-19 pandemic and AAOA member resources…

read more

Today in ENT Allergy: AAOA’s Podcast. Episode 2 – A Brief Overview of the Otolarygnic Allergy

In the second episode of the AAOA's NEW podcast series Today in ENT Allergy: AAOA's…

read more
College Allergy Symptoms Treatment Back to Shcool

PRACTICE RESOURCES

AAOA Practice Resource Tool Kit

The American Academy of Otolaryngic Allergy (AAOA) Practice Resource Tool Kit is intended as a guide to help AAOA members integrate allergy into their otolaryngology practice and to continually improve on this integration as new information, regulations, and resources become available.

Read More

PATIENT CORNER

Menu
AAOA Logo

Practice Resources

Clinical Care Statements

71352956 - portrait of female doctor wearing white coat in office

AAOA Clinical Care Statements 2020

Clinical Care Statements – Updated and Expanded 2020

In response to member requests, your AAOA Board of Directors adopted its original Clinical Care Statements in 2015. To help assure these statements reflect the current practice of medicine, your Board of Directors adopted this expanded and updated compendium in 2020. These statements will continue to be distributed through the AAOA Today, our membership newsletter, and posted on our website www.aaoallergy.org for easy reference for our members. Our intention is to assist otolaryngologists by sharing evidence-based summaries on recommended therapies and practices from the current medical literature. They do not attempt to define a quality of care for legal malpractice proceedings. They should not be taken as recommending for or against a particular company’s products.

The Clinical Care Statements are not meant for patients to use in treating themselves or making decisions about their care. Advances constantly occur in medicine, and some advances will doubtless occur faster than these Clinical Care Statements can be updated. Otolaryngologists will want to keep abreast of the most recent medical literature in deciding the best course for treating their patients.

This compendium of work was only achievable through the tireless efforts of our Clinical Care Statement Workgroup:

Dole Baker, MD
Douglas Dawson, MD
Charles Ebert, MD
Paul Fass, MD
Melissa Hertler, MD
Steve Houser, MD
Ayesha Khalid, MD, MBA
Adrienne Laury, MD
Stella Lee, MD
Andrea Lewis, MD
Sandra Lin, MD
Alpen Patel, MD
Matthew Patterson, MD
Glen Porter, MD
Robert Puchalski, MD
Kenneth Rodriguez, MD
Keith Sale, MD
Kristin Seiberling, MD
Farrah Siddiqui, MD
Robert Stachler, MD
Wesley VanderArk, MD
Christopher Vickery, MD
Kevin Wilson, MD
Mark Zacharek, MD

You can download and print the 2020 Clinical Care Statements Compendium as a whole or each statement individually.

TESTING

Risk Factors for Testing or Immunotherapy
Medicines to Avoid Before Allergy Skin Testing
Skin Testing Techniques for Immediate and Delayed Hypersensitivity Reaction
In Vitro Testing / Allergen-Specific IgE

IMMUNOTHERAPY

Immunotherapy Vial Preparation–Practical Considerations
Subcutaneous Immunotherapy (SCIT) for Aeroallergen Immunotherapy
Sublingual Immunotherapy (SLIT)
Vial Testing
Anaphylaxis
Anaphylaxis Crash Cart Supplies
Allergen Extract Compounding of In-Office Immunotherapy Vials/USP General Chapter <797> Compliance
Optimal Dosing
Duration of Immunotherapy
Home Subcutaneous Immunotherapy

STAFFING AND REGULATIONS

State Regulations on Staffing, Training Requirements, and AP/AH Scope of Service
Nurse Practitioners and Physician Assistants in the Practice of Allergy in the Otolaryngology Office
Available AAOA Resources

Become a Member-Join Now

As a member, you will be eligible for registration fee discounts on all AAOA CME functions and all of our patient education and practice management resources. These savings alone can offset most or all of your dues. Join Today!

Important Information

Please Note

Note:  AAOA’s Clinical Care Statements attempt to assist otolaryngic allergists by sharing summaries of recommended therapies and practices from current medical literature. They do not attempt to define a quality of care for legal malpractice proceedings. They should not be taken as recommending for or against a particular company’s products.  The Statements are not meant for patients to use in treating themselves or making decisions about their care. Advances constantly occur in medicine, and some advances will doubtless occur faster than these Statements can be updated.  Otolaryngic allergists will want to keep abreast of the most recent medical literature in deciding the best course for treating their patients.

New Blog Posts

President’s 2020 Update

Alpen Patel, MD, FAAOA on changes caused by the…

read more
CY 2021 Physician Fee Schedule Proposed Rule Summary

On August 3, the Centers for Medicare & Medicaid…

read more

President Mims Message

April 2017

Working together with AAOA staff, volunteer leadership and members will enable us to have a positive impact on our members’ practices. Read More